Biofrontera Inc. financial data

Symbol
BFRI, BFRIW on Nasdaq
Industry
Pharmaceutical Preparations
Location
120 Presidential Way,, Suite 330, Woburn, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128 % -33.4%
Quick Ratio 53.6 % +10.5%
Debt-to-equity 824 % +407%
Return On Equity -477 % -270%
Return On Assets -50 % -1.81%
Operating Margin -54 % +33.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.54M shares +305%
Common Stock, Shares, Outstanding 5.09M shares +272%
Entity Public Float 14.2M USD -59.9%
Common Stock, Value, Issued 5K USD -81.5%
Weighted Average Number of Shares Outstanding, Basic 5.09M shares +274%
Weighted Average Number of Shares Outstanding, Diluted 5.09M shares +274%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.2M USD +21.3%
Research and Development Expense 621K USD +5545%
Operating Income (Loss) -19M USD +18.9%
Nonoperating Income (Expense) 5.53M USD +587%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.5M USD +40.4%
Income Tax Expense (Benefit) 16K USD +42.9%
Net Income (Loss) Attributable to Parent -13.5M USD +40.4%
Earnings Per Share, Basic -3.12 USD/shares +75.8%
Earnings Per Share, Diluted -3.12 USD/shares +75.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.38M USD -1.66%
Accounts Receivable, after Allowance for Credit Loss, Current 3.75M USD -0.95%
Inventory, Net 3.95M USD -73.3%
Assets, Current 17.5M USD -45.9%
Property, Plant and Equipment, Net 101K USD -42.3%
Operating Lease, Right-of-Use Asset 1.23M USD +11.1%
Intangible Assets, Net (Excluding Goodwill) 2.45M USD -13.3%
Assets 21.6M USD -41.5%
Accounts Payable, Current 1.24M USD +33.5%
Employee-related Liabilities, Current 1.99M USD -29.4%
Accrued Liabilities, Current 3.59M USD -66.5%
Liabilities, Current 9.27M USD -63.4%
Operating Lease, Liability, Noncurrent 443K USD -26.2%
Other Liabilities, Noncurrent 31K USD -22.5%
Liabilities 10.7M USD -64.1%
Retained Earnings (Accumulated Deficit) -110M USD -14%
Stockholders' Equity Attributable to Parent 10.9M USD +52.1%
Liabilities and Equity 21.6M USD -41.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.33M USD +9.87%
Net Cash Provided by (Used in) Financing Activities 5.8M USD
Net Cash Provided by (Used in) Investing Activities -14K USD -180%
Common Stock, Shares Authorized 35M shares +133%
Common Stock, Shares, Issued 5.09M shares +272%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.58M USD -1.59%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.17M USD
Deferred Tax Assets, Valuation Allowance 42.5M USD +17.6%
Deferred Tax Assets, Gross 42.5M USD +17.6%
Operating Lease, Liability 1.14M USD +5.05%
Depreciation 21K USD -4.55%
Payments to Acquire Property, Plant, and Equipment 57K USD +307%
Lessee, Operating Lease, Liability, to be Paid 1.23M USD +6.2%
Property, Plant and Equipment, Gross 691K USD -2.81%
Operating Lease, Liability, Current 701K USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 238K USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year One 582K USD +7.58%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 89K USD +23.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 31K USD
Deferred Tax Assets, Operating Loss Carryforwards 37M USD +21.4%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 20M shares -0.11%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 31K USD
Additional Paid in Capital 121M USD +16.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 420K USD +0.48%
Interest Expense 2.23M USD +55575%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%